- Home
- ADAG vs ANIK Comparison
ADAG vs ANIK Comparison
Compare ADAG & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAG | ANIK |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | China | United States |
| Employees | 138 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.3M | 153.3M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ADAG | ANIK |
|---|---|---|
| Price | $2.96 | $14.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.00 | ★ $16.00 |
| AVG Volume (30 Days) | 108.8K | ★ 143.4K |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.09 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,907,000.00 |
| Revenue This Year | $3,688.61 | $5.20 |
| Revenue Next Year | $17.39 | $4.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.33 | $7.90 |
| 52 Week High | $3.53 | $17.61 |
Technical Indicators
Market Signals| Indicator | ADAG | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 87.62 |
| Support Level | $1.64 | $9.36 |
| Resistance Level | $3.19 | $15.10 |
| Average True Range (ATR) | 0.30 | 0.57 |
| MACD | -0.04 | 0.32 |
| Stochastic Oscillator | 48.01 | 91.49 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.